Overview

Short Course Glucocorticoid Treatment for PTSD

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate if a 2-wk course of 20mg/day of oral prednisone in addition to standard care will result in reduced PTSD symptoms or symptom severity compared to placebo

Phase:

Phase 4

Details

Lead Sponsor:

University of Wisconsin, Madison

Treatments:

Prednisone